GlassScriptPhysician profile
Kimberly Chu
NPI 1699131342
$1,819.90
in general payments reported to CMS, 2019-2025
25 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.95 · 2022: $508 · 2023: $467 · 2024: $601 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,265.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $301.04 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Silk Road Medical, INC. | $163.45 | 2022 | |
| Itamar Medical INC | $149.40 | 2024-2025 | Watchpatone |
| Lilly USA, LLC | $135.93 | 2022-2024 | Mounjaro, Zepbound |
| Idorsia Pharmaceuticals US INC | $123.99 | 2023-2024 | Quviviq |
| Regeneron Healthcare Solutions, INC. | $121.12 | 2023 | Dupixent |
| Astellas Pharma US INC | $115.77 | 2024 | Veozah |
| Amgen INC. | $95.05 | 2024 | Otezla |
| Pfizer INC. | $82.04 | 2022 | |
| Coloplast Corp | $78.80 | 2022 | |
| Convatec INC. | $74.72 | 2024-2025 | |
| Genentech USA, INC. | $45.95 | 2021 | |
| Abbvie INC. | $39.18 | 2022 | |
| Fidia Pharma USA INC. | $37.05 | 2022-2023 | Hymovis, Triluron |
| Takeda Pharmaceuticals U.S.A., INC. | $36.09 | 2024 | Trintellix |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $35.28 | 2023-2025 | Xelstrym |
| Inspire Medical Systems, INC. | $30.92 | 2024 | Inspire |
| Abbott Laboratories | $23.21 | 2022 | |
| Janssen Pharmaceuticals, INC | $22.36 | 2023 | Spravato |
| Corium, LLC | $21.12 | 2023 | Azstarys |
| Pacira Pharmaceuticals Incorporated | $19.75 | 2023 | Zilretta, Iovera |
| Bausch Health US, LLC | $19.25 | 2022 | |
| Exact Sciences Corporation | $17.53 | 2025 | The Cologuard Plus Collection Kit |
| Galderma Laboratories, L.P. | $16.97 | 2022 | |
| Currax Pharmaceuticals LLC | $13.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.